LAUSR

HBV replication inhibitors.

Sign Up to like & get
recommendations!
0 Published in 2020 at "Antiviral research"

DOI: 10.1016/j.antiviral.2020.104815

Abstract: Chronic Hepatitis B Virus infections afflict >250 million people and kill nearly 1 million annually. Current non-curative therapies are dominated by nucleos(t)ide analogs (NAs) that profoundly but incompletely suppress DNA synthesis by the viral reverse… read more here.

Keywords: inhibitors hbv; hbv replication; replication inhibitors; hbv reverse ... See more keywords